PetMeds appoints James LaCamp to board, will chair audit committee

DELRAY BEACH, Fla. - PetMed Express, Inc. (NASDAQ:PETS), operating as PetMeds and parent company of PetCareRx, announced Monday the appointment of James LaCamp to its Board of Directors, effective immediately. LaCamp will also assume the role of Audit Committee Chair on October 30. Track comprehensive board composition changes and their potential impact on company performance with InvestingPro, which offers detailed corporate governance metrics and analysis.

LaCamp brings nearly two decades of experience in finance, accounting, audit, and corporate strategy. He currently serves as Chief Financial Officer at Skydio, a drone technology company, and previously held CFO positions at Flock Safety and senior finance roles at Coupa Software. He also spent over 12 years at Deloitte & Touche LLP as an Audit Partner.

"James is an outstanding addition to our Board," said Leslie C. G. Campbell, Chair of the Board, in a press release statement. Campbell noted that LaCamp’s expertise in audit, accounting, and internal controls would be "critical to our efforts to responsibly pursue the scaling of our business."

LaCamp’s appointment is part of PetMeds’ ongoing board refreshment initiative. Since late 2024, the company has added four new independent directors including Justin Mennen, Leah Solivan, and Peter Batushansky. The board now consists of six directors, five of whom are independent.

The company stated that LaCamp qualifies as an independent director under Nasdaq rules and as an audit committee financial expert under SEC regulations. In addition to chairing the Audit Committee, he will serve on the Compensation and Human Capital Committee.

LaCamp currently serves on the Board of Directors of Performant Healthcare, Inc., where he chairs the audit committee. He holds a B.S.C. in Accounting from Santa Clara University and an M.B.A. from the Wharton School of Business at the University of Pennsylvania.

PetMeds, founded in 1996, operates as an online pet pharmacy licensed across all 50 states, offering pet medications, supplements, and nutrition products.

In other recent news, Schoox has announced the appointment of Sandra Moran as its new Chief Marketing Officer. Moran brings over 25 years of experience in technology marketing to the company. Her previous roles include serving as Chief Marketing and Customer Experience Officer at WorkForce Software, where she played a part in the company’s acquisition by ADP. Additionally, she was the CMO at LLamasoft during its $1.5 billion sale to Coupa Software. These experiences highlight her extensive background in overseeing significant corporate transactions. The appointment is part of Schoox’s ongoing efforts to strengthen its leadership team. This development is expected to enhance the company’s marketing strategies and potentially influence its future growth.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.